Cystic Fibrosis Global Clinical Trials Review, H2, 2016

Publisher Name :
Date: 31-Aug-2016
No. of pages: 456
Inquire Before Buying

Cystic Fibrosis Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, "Cystic Fibrosis Global Clinical Trials Review, H2, 2016" provides an overview of Cystic Fibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystic Fibrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Cystic Fibrosis Global Clinical Trials Review, H2, 2016

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Cystic Fibrosis to Respiratory Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Cystic Fibrosis to Respiratory Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Cystic Fibrosis Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Cystic Fibrosis 30
Aug 16, 2016: Anthera Pharmaceuticals Announces Positive DSMB Review in Phase 3 SOLUTION Study of Sollpura 30
Aug 15, 2016: Vertex Provides Update on Ongoing Phase 3 Program for VX-661 in Combination with Ivacaftor for the Treatment of Cystic Fibrosis 30
Jul 15, 2016: Pharmaxis Completes Recruitment of Pivotol Bronchitol Cystic Fibrosis Clinical Trial for US Market 31
Jul 07, 2016: Nivalis Therapeutics Announces Completion of Enrollment in Phase 2 Study of N91115 for Treatment of Cystic Fibrosis 31
Jul 07, 2016: Protalix BioTherapeutics Announces First Patient Dosed in the AIR DNase Phase II Clinical Trial for Cystic Fibrosis 32
Jun 21, 2016: ProQR to Release Topline Data from Proof of Concept Study of QR-010 in Cystic Fibrosis Patients at NACFC 32
Jun 10, 2016: Vertex Announces Presentation of Data for KALYDECO (ivacaftor) at European Cystic Fibrosis Society Conference 33
Jun 10, 2016: Vertex Announces Presentation of Data for ORKAMBI (lumacaftor/ivacaftor) at European Cystic Fibrosis Society Conference 34
Jun 10, 2016: Raptor Pharmaceutical Announces Presentation of New Data Analyses from a Phase 3 Study of QUINSAIR at the 39th European Cystic Fibrosis Conference 35
Jun 10, 2016: New Analyses from Phase 3 Study 009 of Translarna (ataluren) in Patients with Cystic Fibrosis Presented at 39th European Cystic Fibrosis Conference 36
Jun 10, 2016: Concert Pharmaceuticals Presents CTP-656 Phase 1 Results at European Cystic Fibrosis Conference 36
Jun 07, 2016: Raptor Pharmaceutical to Present Data on QUINSAIR at European Cystic Fibrosis Conference 37
Clinical Trial Profile Snapshots 38
Appendix 453
Abbreviations 453
Definitions 453
Research Methodology 454
Secondary Research 454
About GlobalData 455
Contact Us 455
Disclaimer 455
Source 456

List of Tables
Cystic Fibrosis Therapeutics, Global, Clinical Trials by Region, 2016* 6
Cystic Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Cystic Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Cystic Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Cystic Fibrosis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Cystic Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Cystic Fibrosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
Proportion of Cystic Fibrosis to Respiratory Clinical Trials, G7 Countries (%), 2016* 14
Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Cystic Fibrosis to Respiratory Clinical Trials, E7 Countries (%), 2016* 17
Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Cystic Fibrosis Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Cystic Fibrosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Cystic Fibrosis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Cystic Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Cystic Fibrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Cystic Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Cystic Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Cystic Fibrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures
Cystic Fibrosis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Cystic Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Cystic Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Cystic Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Cystic Fibrosis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Cystic Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Cystic Fibrosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
Proportion of Cystic Fibrosis to Respiratory Clinical Trials, G7 Countries (%), 2016* 14
Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Cystic Fibrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Cystic Fibrosis to Respiratory Clinical Trials, E7 Countries (%), 2016* 17
Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Cystic Fibrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Cystic Fibrosis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Cystic Fibrosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Cystic Fibrosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Cystic Fibrosis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Cystic Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Cystic Fibrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Cystic Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Cystic Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Cystic Fibrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
GlobalData Methodology 454
  • Global Clinical Trials Market Size, Status and Forecast 2022
    Published: 14-Sep-2017        Price: US 3300 Onwards        Pages: 98
    This report studies the global Clinical Trials market, analyzes and researches the Clinical Trials development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Quintiles IMS Holdings - LabCorp (Covance Inc.) - Pharmaceutical Product Development (PPD) - Parexel International Corporation - ICON - INC Research - inVentiv Health - PRA Health......
  • Global Clinical Trial Supplies Market Size, Status and Forecast 2022
    Published: 29-Aug-2017        Price: US 3300 Onwards        Pages: 102
    This report studies the global Clinical Trial Supplies market, analyzes and researches the Clinical Trial Supplies development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - KLIFO A/S - PAREXEL International Corporation - Almac Group Ltd - Movianto GmbH - Patheon Inc. - Biocair International Ltd. - PCI Services - Thermo Fischer Scienti......
  • Cancer Pain Global Clinical Trials Review, H2, 2017
    Published: 23-Aug-2017        Price: US 2500 Onwards        Pages: 274
    GlobalData's clinical trial report, "Cancer Pain Global Clinical Trials Review, H2, 2017" provides an overview of Cancer Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type......
  • Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Global Clinical Trials Review, H2, 2017
    Published: 23-Aug-2017        Price: US 2500 Onwards        Pages: 38
    GlobalData's clinical trial report, "Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) Global Clinical Trials Review, H2, 2017" provides an overview of Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Fibrin Stabilizing Factor Deficiency (Factor XIII Deficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ......
  • Fibrinogen Deficiency (Factor I Deficiency) Global Clinical Trials Review, H2, 2017
    Published: 23-Aug-2017        Price: US 2500 Onwards        Pages: 42
    GlobalData's clinical trial report, "Fibrinogen Deficiency (Factor I Deficiency) Global Clinical Trials Review, H2, 2017" provides an overview of Fibrinogen Deficiency (Factor I Deficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Fibrinogen Deficiency (Factor I Deficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ......
  • Fibromyalgia Global Clinical Trials Review, H2, 2017
    Published: 23-Aug-2017        Price: US 2500 Onwards        Pages: 224
    GlobalData's clinical trial report, "Fibromyalgia Global Clinical Trials Review, H2, 2017" provides an overview of Fibromyalgia clinical trials scenario. This report provides top line data relating to the clinical trials on Fibromyalgia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor t......
  • Fibrosarcoma Global Clinical Trials Review, H2, 2017
    Published: 23-Aug-2017        Price: US 2500 Onwards        Pages: 94
    GlobalData's clinical trial report, "Fibrosarcoma Global Clinical Trials Review, H2, 2017" provides an overview of Fibrosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Fibrosarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor t......
  • Fibrosis Global Clinical Trials Review, H2, 2017
    Published: 23-Aug-2017        Price: US 2500 Onwards        Pages: 129
    GlobalData's clinical trial report, "Fibrosis Global Clinical Trials Review, H2, 2017" provides an overview of Fibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Fibrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report ......
  • Filariasis Global Clinical Trials Review, H2, 2017
    Published: 23-Aug-2017        Price: US 2500 Onwards        Pages: 57
    GlobalData's clinical trial report, "Filariasis Global Clinical Trials Review, H2, 2017" provides an overview of Filariasis clinical trials scenario. This report provides top line data relating to the clinical trials on Filariasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. R......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs